Shareholders greenlight GSK buyback at N17.42 amid delisting process
The minority shareholders of Glaxo SmithKline Consumer Nigeria Plc have given their approval for the acquisition of their shares at the rate of N17.42 per unit as the company finalizes the delisting process from the Nigerian Exchange Limited (NGX). The … Continue reading Shareholders greenlight GSK buyback at N17.42 amid delisting process